Comprehensive guide to PDD in macaws: causes (avian bornavirus), signs, diagnostics, celecoxib and supportive care, biosecurity, monitoring and quality-of-life decisions.

Quick Overview

• What it is: Proventricular dilatation disease (PDD) is a frequently progressive neurologic and gastrointestinal disease of parrots, including macaws, most commonly associated with infection by avian bornavirus (ABV). It causes inflammation of the autonomic nerves that control the gastrointestinal tract and central nervous system.
• Who’s at risk: All macaw species can be affected (scarlet, blue-and-gold, hyacinth, etc.). Birds in mixed collections, breeding facilities, rescues, or with exposure to ABV-positive birds are at higher risk. Young to middle-aged birds are commonly reported, but any age can be affected.
• Prognosis: There is currently no definitive cure. Prognosis ranges from guarded to poor for advanced disease. Some birds respond to anti-inflammatory therapy and intensive supportive care with months to years of improved quality of life; others decline despite treatment.

Pathophysiology — explained simply

PDD results when the bird’s nervous tissue — especially the ganglia (nerve cell clusters) that control the crop, proventriculus (glandular stomach), ventriculus (muscular gizzard), and parts of the central nervous system — becomes inflamed (lymphoplasmacytic ganglioneuritis). The primary infectious agent associated with PDD is avian bornavirus (ABV), an RNA virus able to infect neurons and replicate intermittently. The result is loss of coordinated motility of the GI tract (leading to dilatation, delayed emptying and malabsorption) and a range of neurologic deficits when the CNS is involved (ataxia, tremors, behavioral change).

Breed-specific risk factors and prevalence

• Macaws (Ara spp.) are considered susceptible; PDD has been reported across macaw species. In multi-bird collections, seroprevalence of ABV exposure varies widely (studies report anywhere from low percentages to substantial proportions depending on local outbreaks and testing methods).
• Risk increases with exposure to ABV-positive birds, recent introductions without quarantine, and in facilities lacking strict biosecurity.
• Not every ABV-exposed bird develops clinical PDD — some remain asymptomatic carriers and intermittently shed virus.

Clinical signs and stages

PDD is variable. It commonly presents with a mixture of gastrointestinal (GI) and neurologic signs.

Typical signs

• GI-predominant: progressive weight loss despite appetite, undigested seeds in feces, regurgitation, crop stasis or chronic crop enlargement, vomiting-like behavior, frequent watery droppings, increased crop size after feeding, and visible proventricular enlargement on radiographs.
• Neuro-predominant: ataxia, proprioceptive deficits, tremors, weakness, abnormal head movements, seizures in advanced cases, behavioral changes.

• Stage 1 (early/nonspecific): intermittent regurgitation, mild weight loss, subtle behavior change.
• Stage 2 (established): clear GI signs (recurrent crop stasis, regurgitation, poor fecal quality), +/- neurologic signs.
• Stage 3 (advanced): severe proventricular dilation, pronounced neurologic deficits, marked weight loss or cachexia.

Diagnostic approach

PDD diagnosis can be challenging and often requires a combination of tests. Workup should be coordinated with an avian specialist where possible.

• Detailed history (onset, diet, exposures, new introductions) and repeated weighing (daily to weekly) are essential.

• Plain radiographs: may show proventricular enlargement or severe crop dilation.
• Contrast studies (barium swallow, timed radiographs) or fluoroscopy: helpful to document delayed gastric emptying and to rule out obstructive masses.

• ABV testing: PCR (cloacal swab, choanal swab, crop wash, feces) can detect viral RNA but shedding is intermittent — a single negative PCR does not rule out infection.
• Serology (ABV antibody ELISA/Western blot): indicates exposure; positive antibody with compatible signs supports PDD but neither test alone is definitive.
• Repeated sampling (≥3 tests over weeks) increases diagnostic yield.

• Full-thickness biopsy of proventriculus/ventriculus with histopathology demonstrating lymphoplasmacytic ganglioneuritis is diagnostic. Biopsy carries anesthesia and surgical risk and is best performed by an experienced avian surgeon.

• CBC and chemistry to evaluate hydration, organ function, and for monitoring drug safety during treatment.

• Refer to an avian medicine specialist for advanced imaging (fluoroscopy), biopsy, and complex management planning.

Treatment options

There is no universally effective antiviral therapy for ABV/PDD. Management combines targeted medical therapy (largely anti-inflammatory) and aggressive supportive care.

Medical therapies

• Anti-inflammatory therapy (NSAIDs): Celecoxib is one of the most commonly used COX-2 selective NSAIDs in avian PDD protocols.

• Other anti-inflammatories: meloxicam or other NSAIDs have been used in some cases, and corticosteroids have been tried for severe immune-mediated inflammation, but steroids carry infection risk and are used cautiously.
• Antivirals: no established antiviral therapy for ABV has consistent benefit. Experimental use of agents (e.g., ribavirin) has limited or inconsistent evidence and is not standard care.

• Prokinetics such as cisapride (historically used for motility disorders) have been used to promote gastric emptying; availability varies and use must be under veterinary guidance.
• Gastroprotectants (famotidine, sucralfate) and digestive enzymes or pancreatic supplements may be indicated based on clinical signs.

• Nutritional support: high-calorie, highly digestible diets and assisted feeding. Use critical care diets formulated for birds (e.g., Oxbow Critical Care for birds) and syringe-feeding techniques if the bird will swallow.
• Feeding tubes: for prolonged support, placement of an esophagostomy or crop tube may be discussed with an avian surgeon. Tube feeding allows reliable caloric intake but requires training and hygiene.
• Fluid therapy: correct dehydration and electrolyte disturbances (subcutaneous or intravenous depending on severity).
• Weight monitoring: daily weighing is essential to guide caloric needs and detect decline early.

Surgery does not cure PDD. In rare cases, exploratory surgery is performed for biopsy or to address complications. Long-term feeding tubes are a surgical option for chronic support.

Alternative and adjunctive therapies

• Some owners report temporary improvement with anti-inflammatories, antioxidants, or immune-modulating strategies, but evidence is limited. Avoid unproven or harmful remedies; discuss alternatives with your veterinarian.

Celecoxib: practical notes and safety

• Use only under veterinary prescription. Celecoxib is off-label in birds but is used in many practices for PDD-related inflammation.
• Typical starting concept (veterinary discretion): 5–10 mg/kg PO once daily; some clinicians use divided dosing (q12–24h) or higher ranges in refractory cases. Adjust dose based on response and monitoring.
• Baseline monitoring: CBC, serum biochemistry (renal and liver values) before starting; recheck within 1–2 weeks and periodically thereafter.
• Side effects: inappetence, GI bleeding, renal or hepatic dysfunction have been reported. Stop drug and seek veterinary attention if new bleeding, dark stool, vomiting-like behavior, or sudden change in demeanor occurs.
• Never start NSAIDs without vet guidance, especially if the bird is already on other medications.

Long-term management and monitoring

• Regular rechecks: initially every 1–4 weeks depending on stability, then every 1–3 months once stable. Include weight checks, physical exam, and periodic bloodwork.
• Home monitoring: weigh your bird daily or every other day, document droppings (consistency, color, frequency), watch crop emptying after a meal, and monitor appetite/activity.
• Adjust supportive feeding and medications as needed. Be realistic: many birds require lifelong support and close monitoring; some may have prolonged stable periods.

Biosecurity and prevention

• Quarantine new birds for at least 45–60 days and test them (PCR and serology) with repeat testing before introduction. Because ABV shedding is intermittent and seroconversion variable, quarantine + repeated testing is safer than a single negative test.
• Isolation of clinically affected birds: house ABV-positive or PDD-suspect birds away from negative birds with dedicated equipment and caretakers if possible.
• Personal biosecurity: wear disposable gloves when handling suspect birds; wash hands and change clothes between bird rooms.
• Disinfection: bornaviruses are enveloped and susceptible to many disinfectants. Common practice uses household bleach (diluted 1:32 to 1:10 depending on manufacturer guidance) or approved veterinary disinfectants per label. Clean and disinfect cages, bowls and tools after removal of organic material. Follow facility protocols and consult your veterinarian for specifics.
• Testing and record-keeping: maintain records of tests, clinical signs and weights; consider screening flock contacts periodically.

Prognosis and quality-of-life considerations

• Variable: some birds respond to anti-inflammatory therapy and intensive care with months to years of stable life; others progress despite therapy.
• Key factors: severity at presentation, presence of neurologic deficits, response to therapy, owner ability to provide long-term supportive care, and risk of secondary complications (aspiration, severe malnutrition).
• Euthanasia: when suffering cannot be controlled (intractable weight loss despite feeding, unmanageable pain or severe neurologic compromise affecting quality of life), discuss humane euthanasia with your veterinarian.

Living with PDD — practical daily tips

• Daily weigh-ins: use the same scale and time each day; a 5–10% weight change is significant.
• Observe droppings and crop emptying: keep a photo log if helpful.
• Feeding: offer small, frequent, easily digestible meals. Use warmed critical care formula if assisted feeding is required.
• Hygiene: dedicated food bowls and cleaning tools for affected bird(s); clean cages and perches more frequently.
• Enrich carefully: provide low-stress enrichment; avoid large flights if bird is weak.
• Medication adherence: give medications exactly as prescribed; record doses given.
• Communication: maintain close contact with your avian vet and ask for referrals to an avian specialist if needed.

When to See Your Vet Urgently

Seek immediate veterinary care if your macaw has:

• Sudden inability or refusal to swallow, persistent regurgitation or repeated choking episodes.
• Rapid weight loss (>5–10% of body weight in a few days), severe weakness or collapse.
• Respiratory distress (open-mouth breathing, tail bobbing, gasping).
• Seizures, recumbency or severe neurologic deterioration.
• Evidence of GI bleeding (black, tarry droppings, blood in droppings) or sudden dramatic change while on medications like NSAIDs.

Key takeaways

• PDD/ABV is a complex disease of macaws involving inflammation of autonomic and central nerves; diagnosis often requires repeated testing and imaging and sometimes biopsy.
• No reliable cure exists. Celecoxib and other anti-inflammatory strategies can help some birds — always use under veterinary supervision with baseline monitoring.
• Supportive care (nutrition, fluids, prokinetics where appropriate) and strict biosecurity are central to management.
• Work closely with an avian vet and consider specialist referral for diagnostics, surgical biopsy, and advanced care planning.

Sources and further reading: Merck Veterinary Manual (Proventricular Dilatation Disease), ACVIM/avian medicine reviews, Kistler et al. (2008) and Gancz et al. (2009) papers linking avian bornavirus to PDD, and institutional avian medicine resources (Cornell, university avian hospitals).

Frequently Asked Questions